Share on StockTwits

Ducommun (NYSE:DCO) was downgraded by stock analysts at DA Davidson from a “buy” rating to a “neutral” rating in a report issued on Friday, TheFlyOnTheWall.com reports. They currently have a $34.00 price target on the stock, up from their previous price target of $28.00. DA Davidson’s target price suggests a potential upside of 7.53% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks upgraded shares of Ducommun from a “neutral” rating to an “outperform” rating in a research note on Wednesday, July 30th. They now have a $29.80 price target on the stock. Analysts at Topeka Capital Markets initiated coverage on shares of Ducommun in a research note on Tuesday, June 24th. They set a “hold” rating and a $27.00 price target on the stock. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Ducommun currently has an average rating of “Buy” and a consensus price target of $32.11.

Shares of Ducommun (NYSE:DCO) opened at 31.60 on Friday. Ducommun has a one year low of $22.45 and a one year high of $32.00. The stock has a 50-day moving average of $26.69 and a 200-day moving average of $25.73. The company has a market cap of $344.3 million and a P/E ratio of 31.12.

Ducommun (NYSE:DCO) last announced its earnings results on Monday, July 28th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.15. The company had revenue of $186.50 million for the quarter, compared to the consensus estimate of $189.63 million. During the same quarter in the previous year, the company posted $0.51 earnings per share. The company’s revenue for the quarter was down 2.6% on a year-over-year basis. Analysts expect that Ducommun will post $1.92 EPS for the current fiscal year.

Ducommun Incorporated (NYSE:DCO) provides engineering and manufacturing services primarily in the aerospace, defense, industrial, energy, and medical industries.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.